The National Rugby League (NRL) Anti-Doping Tribunal has imposed a 20-month suspension on former NRL Player James Segeyaro.
The Anti-Doping Tribunal, chaired by the Honourable Ian Callinan AC QC with panellists Dr Sharron Flahive and Mr Sean Garlick, found that Mr Segeyaro breached the NRL’s Anti-Doping Policy in September 2019 when he tested positive to the presence of Di-Hydroxy LGD-4033 (Ligandrol).
In considering the circumstances of the breach, the Tribunal found that whilst Mr Segeyaro bore a significant degree of responsibility for the positive result, he had not intentionally taken the Ligandrol, which was likely to have entered his system via the use of a food blender maintained by a member of his household that contained residues of the substance. Having been satisfied that the doping was not intentional, the Tribunal determined that Mr Segeyaro was entitled to a reduced sanction under the WADA Code.
Mr Segeyaro’s suspension is taken to have commenced on the date of his provisional suspension on 3 October 2019 and will expire on 2 June 2021.
